FLT4 Antikörper
Kurzübersicht für FLT4 Antikörper (ABIN969147)
Target
Alle FLT4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- FLT4 Antibody
-
Aufreinigung
- Ascitic fluid
-
Immunogen
- Purified recombinant fragment of human FLT4 expressed in E. Coli.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- ELISA: 1/10000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Ascitic fluid containing 0.03 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
-
: "Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines." in: The Prostate, Vol. 69, Issue 9, pp. 982-90, (2009) (PubMed).
: "Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells." in: Journal of cell science, Vol. 122, Issue Pt 18, pp. 3358-64, (2009) (PubMed).
: "Endothelial VEGFR-3 expression in colorectal carcinomas is associated with hematogenous metastasis." in: Oncology reports, Vol. 22, Issue 5, pp. 1093-100, (2009) (PubMed).
-
-
- FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))
-
Andere Bezeichnung
- FLT4
-
Hintergrund
- This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. Tissue specificity: Placenta, lung, heart, and kidney, does not seem to be expressed in pancreas and brain. VEGFR-3 is induced in all endothelial cells (EC
-
Molekulargewicht
- 145 kDa
-
Gen-ID
- 2324
-
UniProt
- P35916
-
Pathways
- RTK Signalweg, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling
Target
-